US President Donald Trump has imposed a 100% tariff on imported branded pharma drugs to boost domestic manufacturing. Experts say India’s generic drug exports remain mostly unaffected for now, though market sentiment took a hit with pharma stocks falling. Concerns remain that future US tariffs might extend to generics, which could disrupt India’s pharma sector and investor confidence.